J&J ETFs to Gain on Upbeat COVID-19 Vaccine Data Posted bySweta Jaiswal, FRM September 24, 2021 Leave a comment on J&J ETFs to Gain on Upbeat COVID-19 Vaccine Data The positive data update has put the spotlight on a number of ETFs that could benefit from their high exposure to Johnson & Johnson.